Effect of protein, unsaturated fat, and carbohydrate intakes on plasma apolipoprotein B and VLDL and LDL containing apolipoprotein C-III: results from the OmniHeart Trial

Am J Clin Nutr. 2008 Jun;87(6):1623-30. doi: 10.1093/ajcn/87.6.1623.

Abstract

Background: Plasma apolipoprotein B (apo B) and VLDL and LDL with apolipoprotein C-III (apo C-III) are independent risk factors for cardiovascular disease (CVD). Dietary intake affects lipoprotein concentration and composition related to those apolipoproteins.

Objective: We studied differences in apo B lipoproteins with and without apo C-III after 3 healthy diets based on the Dietary Approaches to Stop Hypertension Trial diet.

Design: Healthy participants (n = 162) were fed each of 3 healthy diets for 6 wk in a crossover design. Diets differed by emphasis of either carbohydrate (Carb), unsaturated fat (Unsat), or protein (Prot). Blood was collected at baseline and after diets for analysis.

Results: Compared with the Carb diet, the Prot diet reduced plasma apo B and triglycerides in VLDL with apo C-III (16%, P = 0.07; 11%, P = 0.05, respectively) and apo B in LDL with apo C-III (16%, P = 0.04). Compared with the Unsat diet, the Prot diet reduced triglycerides in VLDL with apo C-III (16%, P = 0.02). Compared with baseline (subjects' usual diet was higher in saturated fat), the Prot diet reduced apo B in LDL with apo C-III (11%, P = 0.05), and all 3 diets reduced plasma total apo B (6-10%, P < 0.05) and apo B in the major type of LDL, LDL without apo C-III (8-10%, P < 0.01). All 3 diets reduced the ratio of apo C-III to apo E in VLDL.

Conclusions: Substituting protein for carbohydrate in the context of a healthy dietary pattern reduced atherogenic apo C-III-containing LDL and its precursor, apo C-III-containing VLDL, resulting in the most favorable profile of apo B lipoproteins. In addition, compared with a typical high-saturated fat diet, healthy diets that emphasize carbohydrate, protein, or unsaturated fat reduce plasma total and LDL apo B and produce a lower more metabolically favorable ratio of apo C-III to apo E.

Publication types

  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Apolipoprotein C-III / blood
  • Apolipoprotein C-III / drug effects
  • Apolipoproteins B / blood*
  • Apolipoproteins B / drug effects
  • Blood Proteins / metabolism
  • Cross-Over Studies
  • Dietary Carbohydrates*
  • Dietary Fats, Unsaturated*
  • Dietary Proteins*
  • Energy Intake
  • Humans
  • Lipids / blood
  • Lipoproteins, LDL / blood*
  • Lipoproteins, LDL / drug effects
  • Lipoproteins, VLDL / blood*
  • Lipoproteins, VLDL / drug effects
  • Male
  • National Heart, Lung, and Blood Institute (U.S.)
  • United States

Substances

  • Apolipoprotein C-III
  • Apolipoproteins B
  • Blood Proteins
  • Dietary Carbohydrates
  • Dietary Fats, Unsaturated
  • Dietary Proteins
  • Lipids
  • Lipoproteins, LDL
  • Lipoproteins, VLDL